雅培
ABT131.420USD
-2.310-1.73%
收盘 09/15, 16:00（美东）报价延迟15分钟
228.73B总市值
16.36市盈率 TTM
关于 雅培 公司
雅培是一家横跨全球的医疗保健领导者，专注于多元健康产品的研发、制造与销售，业务框架涵盖四大单元：成熟药品、诊断、营养以及医疗器械。成熟药品单元负责多品牌仿制药的国际行销；诊断单元向血库、医院、商业实验室与替代护理点提供检测系统与试剂；营养单元经营成人及儿童营养品全球通路；医疗器械单元销售节律管理、电生理、心衰、血管、结构心脏、神经调控及糖尿病护理装置，持续推动创新改善患者生命品质。其全球供应链覆盖六大洲，利用数据分析与可持续制造提升效率与品质保障。
公司简介
公司代码ABT
公司名称Abbott Laboratories
上市日期Mar 01, 1937
CEOMr. Robert B. Ford
员工数量114000
证券类型Ordinary Share
年结日Mar 01
公司地址100 Abbott Park Road
城市ABBOTT PARK
上市交易所NYSE Consolidated
国家United States of America
邮编60064-3500
电话12246676100
网址https://www.abbott.com
公司代码ABT
上市日期Mar 01, 1937
CEOMr. Robert B. Ford
公司高管
名称
名称/职务
职务
持股
持股变动
Mr. Daniel J. Starks
Mr. Daniel J. Starks
Independent Director
Independent Director
6.73M
+0.02%
Mr. Hubert L. Allen
Mr. Hubert L. Allen
Executive Vice President, General Counsel, Secretary
Executive Vice President, General Counsel, Secretary
191.90K
+3.84%
Mr. Daniel Gesua Sive Salvadori
Mr. Daniel Gesua Sive Salvadori
Executive Vice President, Group President - Established Pharmaceuticals and Nutritional Products
Executive Vice President, Group President - Established Pharmaceuticals and Nutritional Products
133.77K
+6.42%
Ms. Mary K. Moreland
Ms. Mary K. Moreland
Executive Vice President - Human Resources
Executive Vice President - Human Resources
95.58K
-0.82%
Ms. Lisa D. Earnhardt
Ms. Lisa D. Earnhardt
Executive Vice President, Group President - Medical Devices
Executive Vice President, Group President - Medical Devices
71.93K
--
Mr. Louis H. (Lou) Morrone
Mr. Louis H. (Lou) Morrone
Executive Vice President - Core Diagnostics
Executive Vice President - Core Diagnostics
66.61K
-0.40%
Mr. Philip P. Boudreau
Mr. Philip P. Boudreau
Chief Financial Officer, Executive Vice President - Finance
Chief Financial Officer, Executive Vice President - Finance
50.97K
-0.75%
Dr. Robert J. Alpern, M.D.
Dr. Robert J. Alpern, M.D.
Independent Director
Independent Director
40.80K
+4.17%
Ms. Nancy Mckinstry
Ms. Nancy Mckinstry
Lead Independent Director
Lead Independent Director
38.72K
+4.41%
Ms. Sally E. Blount, Ph.D.
Ms. Sally E. Blount, Ph.D.
Independent Director
Independent Director
34.06K
-2.76%
查看更多
名称
名称/职务
职务
持股
持股变动
Mr. Daniel J. Starks
Mr. Daniel J. Starks
Independent Director
Independent Director
6.73M
+0.02%
Mr. Hubert L. Allen
Mr. Hubert L. Allen
Executive Vice President, General Counsel, Secretary
Executive Vice President, General Counsel, Secretary
191.90K
+3.84%
Mr. Daniel Gesua Sive Salvadori
Mr. Daniel Gesua Sive Salvadori
Executive Vice President, Group President - Established Pharmaceuticals and Nutritional Products
Executive Vice President, Group President - Established Pharmaceuticals and Nutritional Products
133.77K
+6.42%
Ms. Mary K. Moreland
Ms. Mary K. Moreland
Executive Vice President - Human Resources
Executive Vice President - Human Resources
95.58K
-0.82%
Ms. Lisa D. Earnhardt
Ms. Lisa D. Earnhardt
Executive Vice President, Group President - Medical Devices
Executive Vice President, Group President - Medical Devices
71.93K
--
Mr. Louis H. (Lou) Morrone
Mr. Louis H. (Lou) Morrone
Executive Vice President - Core Diagnostics
Executive Vice President - Core Diagnostics
66.61K
-0.40%
收入明细
单位: USD更新时间: 7月6日 周日
单位: USD更新时间: 7月6日 周日
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
业务USD
名称
营收
占比
Diabetes Care
1.83B
17.64%
Core Laboratory
1.18B
11.36%
Adult Nutritionals
1.10B
10.67%
Pediatric Nutritionals
1.04B
10.05%
Key Emerging Markets
965.00M
9.32%
其他
4.24B
40.96%
地区USD
名称
营收
占比
All other Countries
6.19B
59.76%
United States
4.17B
40.24%
业务
地区
业务USD
名称
营收
占比
Diabetes Care
1.83B
17.64%
Core Laboratory
1.18B
11.36%
Adult Nutritionals
1.10B
10.67%
Pediatric Nutritionals
1.04B
10.05%
Key Emerging Markets
965.00M
9.32%
其他
4.24B
40.96%
股东统计
更新时间: 8月15日 周五
更新时间: 8月15日 周五
持股股东
股东类型
持股股东
持股股东
占比
The Vanguard Group, Inc.
9.88%
BlackRock Institutional Trust Company, N.A.
5.09%
State Street Global Advisors (US)
4.50%
Capital International Investors
3.46%
Capital Research Global Investors
2.40%
其他
74.67%
持股股东
持股股东
占比
The Vanguard Group, Inc.
9.88%
BlackRock Institutional Trust Company, N.A.
5.09%
State Street Global Advisors (US)
4.50%
Capital International Investors
3.46%
Capital Research Global Investors
2.40%
其他
74.67%
股东类型
持股股东
占比
Investment Advisor
46.42%
Investment Advisor/Hedge Fund
23.17%
Research Firm
3.60%
Bank and Trust
2.24%
Pension Fund
2.21%
Sovereign Wealth Fund
1.37%
Insurance Company
1.06%
Individual Investor
0.48%
Hedge Fund
0.44%
其他
18.99%
机构持股
更新时间: 7月1日 周二
更新时间: 7月1日 周二
报告期
机构数
持股数
持股占比
持股变动
2025Q2
4616
1.41B
81.28%
+6.94M
2025Q1
4644
1.42B
81.42%
+12.91M
2024Q4
4535
1.39B
80.22%
+15.89M
2024Q3
4391
1.36B
78.29%
-11.85M
2024Q2
4400
1.36B
78.24%
-7.03M
2024Q1
4402
1.35B
77.67%
-9.71M
2023Q4
4429
1.35B
77.56%
-11.05M
2023Q3
4298
1.34B
77.39%
-25.33M
2023Q2
4297
1.35B
77.60%
-13.55M
2023Q1
4281
1.35B
77.46%
-8.61M
查看更多
股东持股明细
名称
持股数
占比
持股变动
变动比例
公告日期
The Vanguard Group, Inc.
169.07M
9.72%
+1.18M
+0.70%
Mar 31, 2025
BlackRock Institutional Trust Company, N.A.
87.82M
5.05%
+752.19K
+0.86%
Mar 31, 2025
State Street Global Advisors (US)
77.66M
4.46%
+497.07K
+0.64%
Mar 31, 2025
Capital International Investors
66.82M
3.84%
-1.15M
-1.69%
Mar 31, 2025
Capital Research Global Investors
50.73M
2.92%
-3.36M
-6.22%
Mar 31, 2025
Geode Capital Management, L.L.C.
36.90M
2.12%
+1.23M
+3.46%
Mar 31, 2025
JP Morgan Asset Management
28.80M
1.66%
+3.67M
+14.58%
Mar 31, 2025
Wellington Management Company, LLP
29.76M
1.71%
+3.37M
+12.77%
Mar 31, 2025
Norges Bank Investment Management (NBIM)
20.98M
1.21%
+626.72K
+3.08%
Dec 31, 2024
Wells Fargo Advisors
15.42M
0.89%
+165.54K
+1.09%
Mar 31, 2025
查看更多
持股ETF
更新时间: 9月2日 周二
更新时间: 9月2日 周二
机构名称
占比
iShares U.S. Medical Devices ETF
16.79%
Goldman Sachs Future Health Care Equity ETF
6.3%
GMO US Quality ETF
5.19%
Invesco Pharmaceuticals ETF
4.64%
Polen Capital Global Growth ETF
4.64%
iShares U.S. Healthcare ETF
4.45%
Proshares Ultra Health Care
4.45%
Health Care Select Sector SPDR Fund
4.38%
AdvisorShares Focused Equity ETF
4.37%
Tema Heart & Health ETF
4.31%
查看更多
iShares U.S. Medical Devices ETF
占比16.79%
Goldman Sachs Future Health Care Equity ETF
占比6.3%
GMO US Quality ETF
占比5.19%
Invesco Pharmaceuticals ETF
占比4.64%
Polen Capital Global Growth ETF
占比4.64%
iShares U.S. Healthcare ETF
占比4.45%
Proshares Ultra Health Care
占比4.45%
Health Care Select Sector SPDR Fund
占比4.38%
AdvisorShares Focused Equity ETF
占比4.37%
Tema Heart & Health ETF
占比4.31%
分红派息
近5年累计派现
16.46B
美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
Dec 13, 2024
ABT.NB Interim Cash Dividend of gross USD 0.59 paid on Feb 14, 2025 going ex on Jan 15, 2025 with reinvestment option
Jan 15, 2025
Feb 14, 2025
Jan 15, 2025
Sep 19, 2024
ABT.NB Final Cash Dividend of gross USD 0.55 paid on Nov 15, 2024 going ex on Oct 15, 2024
Oct 15, 2024
Nov 15, 2024
Oct 15, 2024
Jun 15, 2024
ABT.NB Interim Cash Dividend of gross USD 0.55 paid on Aug 15, 2024 going ex on Jul 15, 2024 with reinvestment option
Jul 15, 2024
Aug 15, 2024
Jul 15, 2024
Feb 16, 2024
ABT.NB Interim Cash Dividend of gross USD 0.55 paid on May 15, 2024 going ex on Apr 12, 2024
Apr 15, 2024
May 15, 2024
Apr 12, 2024
Dec 15, 2023
ABT.NB Interim Cash Dividend of gross USD 0.55 paid on Feb 15, 2024 going ex on Jan 11, 2024 with reinvestment option
Jan 12, 2024
Feb 15, 2024
Jan 11, 2024
Sep 21, 2023
ABT.NB Final Cash Dividend of gross USD 0.51 paid on Nov 15, 2023 going ex on Oct 12, 2023 with reinvestment option
Oct 13, 2023
Nov 15, 2023
Oct 12, 2023
Jun 09, 2023
ABT.NB Interim Cash Dividend of gross USD 0.51 paid on Aug 15, 2023 going ex on Jul 13, 2023 with reinvestment option
Jul 14, 2023
Aug 15, 2023
Jul 13, 2023
Feb 17, 2023
ABT.NB Interim Cash Dividend of gross USD 0.51 paid on May 15, 2023 going ex on Apr 13, 2023 with reinvestment option
Apr 14, 2023
May 15, 2023
Apr 13, 2023
Dec 09, 2022
ABT.NB Interim Cash Dividend of gross USD 0.51 paid on Feb 15, 2023 going ex on Jan 12, 2023 with reinvestment option
Jan 13, 2023
Feb 15, 2023
Jan 12, 2023
Sep 15, 2022
ABT.NB Final Cash Dividend of gross USD 0.47 paid on Nov 15, 2022 going ex on Oct 13, 2022 with reinvestment option
Oct 14, 2022
Nov 15, 2022
Oct 13, 2022
查看更多
拆合股
公告日期
类型
比率
暂无数据
公告日期
类型
比率
暂无数据
